AEON Biopharma Schedules June 17 Meeting, Cash Runway Into Q3 2026
AEON Biopharma will hold its annual shareholder meeting at 10:00 am PT on June 17, 2026 in Irvine, California, with materials available around April 29, 2026. Its fiscal 2025 audit included a going concern qualification due to its liquidity position, with cash and equivalents expected to fund operations into Q3 2026.
1. Annual Shareholder Meeting Details
AEON Biopharma will convene its Annual Shareholder Meeting at 10:00 am Pacific Time on June 17, 2026 at its Irvine, California headquarters located at 5 Park Plaza, Suite 1750. Meeting materials will be distributed to shareholders on or about April 29, 2026 to facilitate voting on board and corporate matters.
2. Audit Qualification and Cash Runway
The company’s audited consolidated financial statements for the year ended December 31, 2025 carried a going concern qualification, reflecting its development-stage liquidity position. AEON reports that its current cash and cash equivalents are sufficient to fund operations through the third quarter of 2026, subject to ongoing capital requirements.